Naiqing Ding

nanjing university

H指数:11

被引数:816

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer (vol 365, 104376, 2021)

脂溶性重组蛋白插入赋予EGFR阳性癌症淋巴细胞增强的靶向浸润能力（卷 365，104376，2021）

Cellular Immunology

IF2.9

2026-07-010

PRE

Prognostic impact of baseline blood biomarkers in SCLC first-line treatment

小细胞肺癌一线治疗中基线血液生物标志物的预后影响

Therapeutic Advances in Medical Oncology

IF4.2

2026-05-250

PRE

Integrated circulating tumor DNA-based prognostic algorithm for limited stage small-cell lung cancer under definitive chemoradiotherapy and utility in consolidation immunotherapy benefit prediction

基于整合循环肿瘤DNA的局限期小细胞肺癌预后算法，在根治性化放疗下及其在巩固免疫治疗获益预测中的应用

Cell Communication and Signaling

IF8.9

2025-11-080

OAAI

Neoadjuvant sintilimab in combination with concurrent chemoradiotherapy for locally advanced gastric or gastroesophageal junction adenocarcinoma: a single-arm phase 2 trial

NATURE COMMUNICATIONS

IF15.7

2023-08-1421

OAAI

Membrane fusogenic nanoparticle-based HLA-peptide-addressing universal T cell receptor-engineered T (HAUL TCR-T) cell therapy in solid tumor

基于膜融合纳米颗粒的HLA-肽-解决实体瘤中的通用T细胞受体工程T (HAUL tcr-t) 细胞疗法

BIOENGINEERING & TRANSLATIONAL MEDICINE

IF5.7

2023-08-074

OAAI

Hepatoid adenocarcinoma of the duodenal papilla with hepatic metastases: A case report and literature review

FRONTIERS IN ONCOLOGY

IF3.3

2022-08-083

OAAI

In situ antigen modification-based target-redirected universal chimeric antigen receptor T (TRUE CAR-T) cell therapy in solid tumors

基于原位抗原修饰的靶向重定向通用嵌合抗原受体T (TRUE car-t) 细胞疗法在实体瘤中的应用

JOURNAL OF HEMATOLOGY & ONCOLOGY

IF40.4

2022-03-1815

OAAI

Lipophilic recombinant-protein insertion endows lymphocytes with enhanced targeting-infiltration ability in EGFR positive cancer

CELLULAR IMMUNOLOGY

IF2.9

2021-07-010

PREAI

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma

FRONTIERS IN ONCOLOGY

IF3.3

2021-06-046

OAAI

Bifunctional iRGD-anti-CD3 enhances antitumor potency of T cells by facilitating tumor infiltration and T-cell activation

JOURNAL FOR IMMUNOTHERAPY OF CANCER

IF10.6

2021-05-1331

OAAI

Tumor-penetrating peptide fused EGFR single-domain antibody enhances radiation responses following EGFR inhibition in gastric cancer (vol 40, pg 1583, 2018)

ONCOLOGY REPORTS

IF3.9

2020-11-041

Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2019-04-08168

OAAI

iRGD synergizes with PD-1 knockout immunotherapy by enhancing lymphocyte infiltration in gastric cancer

NATURE COMMUNICATIONS

IF15.7

2019-03-2288

OAAI

Lipid insertion enables targeted functionalization of paclitaxel-loaded erythrocyte membrane nanosystem by tumor-penetrating bispecific recombinant protein

INTERNATIONAL JOURNAL OF NANOMEDICINE

IF6.5

2018-09-0169

OAAI

Tumor-penetrating peptide fused EGFR single-domain antibody enhances radiation responses following EGFR inhibition in gastric cancer

ONCOLOGY REPORTS

IF3.9

2018-06-2710

OAAI

CRISPR-Cas9-mediated disruption of PD-1 on human T cells for adoptive cellular therapies of EBV positive gastric cancer

ONCOIMMUNOLOGY

IF6.3

2016-11-2278

OAAI

Microcystin (-LR) induced testicular cell apoptosis via up-regulating apoptosis-related genes in vivo

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2013-10-0139

PREAI

Naiqing Ding

个人简介

教育背景

工作经历

荣誉奖项

研究方向